CUSIP: 14740B101
Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
89,396,217
-
Share change
-
+88,278,556
-
Total reported value
-
$84,272,571
-
Put/Call ratio
-
455%
-
Price per share
-
$0.94
-
Number of holders
-
67
-
Value change
-
+$83,218,571
-
Number of buys
-
66
Quarterly Holders Quick Answers
What is CUSIP 14740B101?
CUSIP 14740B101 identifies CASC - CASCADIAN THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 14740B101:
Institutional Holders of CASCADIAN THERAPEUTICS INC - COM (CASC) as of Q2 2016
As of 30 Jun 2016,
CASCADIAN THERAPEUTICS INC - COM (CASC) was held by
67 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
89,396,217 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, BVF INC/IL, NEA Management Company, LLC, FRANKLIN RESOURCES INC, venBio Select Advisor LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., EverPoint Asset Management, LLC, and BlackRock Fund Advisors.
This page lists
67
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.